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Introduction 
Several oxidoreductases need molybdenum as a co-
factor which, in association with a coenzyme, is the 
active center of these enzymes. 
Now it is well established that most of them do not 
exhibit a fluorescence in their natural state, while they 
turn fluorescent as soon as they are denatured or 
oxidized. Furthermore we know that the origin of the 
fluorescence is the oxidized coenzyme, called molybd-
opterin because it is a C(6)-substituted pterin, which 
might be the same for all molybdenum-enzymes or, 
at least, nearly similar. Unfortunately none of the 
proposed structures for this coenzyme have been 
proven by synthesis. The coenzyme(s) must occur as 
reduced pterin(s) in the natural and active enzymes 
(For a review of the matter see (2)). 
We have studied with 6ß-5,6,7,8-tetrahydro-L-
biopterin3 ' (BH4) as a model compound the possible 
bonds existing between M o and the reduced coen-
zymes in the molybdenum enzymes. 
25 years ago we were faced with a similar problem, 
when wc studied the reaction mechanism of the phen-
ylalanine hydroxylase. The coenzyme of this enzyme 
is (BH4) and the cofactor Fe(III). We demonstrated 
" Part 90 (1) 
2) New address: Anorganisch Chemisches Institut der Univer-
sität, Winterthurerstrasse 190, CH-8057 Zürich. 
31 We used for the hydropterins the consequent and unequivocal 
nomenclature proposed by us (3). According to CIP-rules the 
stereochemistry of this substance has to be described as 
6R,1'R,2'S. 
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with a N(5)-methyltetrahydropterin derivative as a 
model substance, that two pterin molecules formed a 
brown colored complex with one Fe(III) ion. This 
complex activates molecular oxygen which, in con-
séquence, oxidizes the tetrahydropterin (4). 
Results and Discussion 
In a similar manner M 0 l / 0 2 C 1 2 reacts with BH4 and 
forms a nearly quantitative dark red complex with a 
characteristic UV spectrum, corresponding to a re-
duced pterin plus a new maximum at 487 nm. 
Crystallization of the complex was possible and the 
crystal structure could be solved by by X-ray diffrac-
tion (Fig. 1). The complex crystallizes in the non-
centrosymmetric orthorhombic space group Υ Ι ^ Ι ι 
Figure 1. 
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Figure 2. 
(Nr. 19) with unit cell dimensions a = 1009,3(3) pm, 
b = 1104,7(3) pm, c = 1484,5(4) pm and Ζ = 4. The 
molybdenum atom has a distorted octahedral geom-
etry. It is coordinated by N(5) and 0(4) of the pterin 
ligand. The distance of the Mo-N(5) bond (202 pm) 
is unusually short compared to similar complexes. 
0(4) is located trans to a terminal oxo ligand. The 
octahedral coordination is completed by three chlor-
ine atoms in a meridional arrangement. 
The obtained data demonstrated that BH4 was par-
tially oxidized to a quinonoid derivative with the 
possible mesomeric structures I, 2, 3 and 4 (Fig. 2). 
An analysis of the bond lengths shows similar dis-
tances of 132-134 pm between the atoms N(2)-C(2)-
N(l)-C(8a)-N(8) indicating that the mesomeric struc-
tures 1 and 2 are the predominant species. 
The distance of the C(4a)-C(8a) bond is 143 pm and 
the mesomeric system 1 <-> 3 can therefore be ex-
cluded. 
The clearly found proton at the N(3)-atom and the 
long bond distance of 139 pm for N(3)-C(2) rules out 
an endocyclic 7,8-dihydro(6H)biopterin form 4 with 
a N(3) —C(2) double bond (7<->4). An endocyclic 
7,8-dihydro(6H)biopterin tautomer has been pro-
posed by several authors to be reduced to BH4 by 
dihydropteridine reductase [DHPR (human)] (5, 6, 7). 
In solution the quinonoid structure 1 may be prefer-
able in the mesomeric system 1 <-> 2, because it fa-
vours the well known 7,8-dihydro rearrangement 
1 <-> 5 by a facile deprotonation. The complex there-
fore could be formulated as N(2) — N(8)-mesomeric 
trichloro(6ß-quinonoid-6,7-dihydro(8H)-L-biopterin) 
oxomolybdenum(IV). 
The complex, dissolved in methanol, slowly forms an 
equilibrium with the initial reactants: 
_ _ , /!„ -»—TT ^ T T Methanol Mo O2CI2 + BH4 • 2 HCl • 
Me'hano'» Mo"'OCl3(H-quinonoid)BH2 + Η ,Ο + HCl | 
Mo"OCl3(H-quinonoid)BH2 + CH3OH ^ 
Mo"OC13(OCH3) + BH4 
This could be demonstrated by 1 3C-NMR spectros-
copy. For the first time it could be shown that a 
quinonoid-dihydrobiopterin might be converted to a 
tetrahydrobiopterin in the presence of a transition 
metal. 
This complex, with the molybdenum in the enzyme-
relevant oxidation state + IV should lead to an ex-
tension of the proposed common molybdenum cofactor 
model. In the reduced form of the cofactor the mo-
lybdenum atom should be coordinated by a quinonoid 
7,8-dihydro(6H)pterin. 
The tables of the bond distances and angles, the 
experimental and the " C - N M R data were published 
in Helvetica Chimica Acta (1). 
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